Very simple.

The need to innovate and streamline operations. India, especially, the pharmaceutical companies are hard pressed for the scale of operations. You can find this wave of acquisition happening across the verticals, right from pharma to banking sector, every player in a market like India will look to seek the advantage of scalability. All can not be like Reliance Industries which will start from scratch. So you can see this trend going further stronger in the coming days.